Filter
1935
Filtered Results: 1935
Text search:
human
pathogens
Featured
Recommendations
281
New Publications
413
Language
Document type
No document type
797
Studies & Reports
401
Guidelines
399
Manuals
130
Strategic & Response Plan
96
Fact sheets
51
Training Material
34
Situation Updates
14
Brochures
5
Resource Platforms
3
Online Courses
3
Infographics
2
Countries / Regions
Global
91
India
66
Africa
51
South Africa
46
Sierra Leone
45
Western and Central Europe
37
Ethiopia
36
Liberia
36
Nigeria
35
Kenya
34
Latin America and the Carribbean
31
Tanzania
23
Congo, Democratic Republic of
22
Germany
21
Uganda
21
Ghana
20
Rwanda
19
Guinea
19
Nepal
18
West and Central Africa
17
Burkina Faso
15
Bangladesh
15
Ukraine
14
Philippines
14
Russia
14
East and Southern Africa
13
Senegal
11
Malawi
11
Brazil
11
Zambia
11
Syria
10
Middle East and North Africa
10
Côte d’Ivoire / Ivory Coast
10
Mali
10
Myanmar / Burma
10
South–East Asia Region
9
Namibia
9
South Sudan
9
Zimbabwe
8
Colombia
7
Lesotho
7
Cameroon
6
Mozambique
6
Western Pacific Region
6
Eastern Europe and Central Asia
6
Eastern Europe
6
Chad
6
Thailand
5
USA
5
Vietnam
5
Eswatini/ Swaziland
5
China
4
Niger
4
Asia
4
Venezuela
4
Spain
4
Indonesia
4
Togo
3
Laos
3
Peru
3
Saudi Arabia
3
Sudan
3
Yemen
3
Central African Republic
3
Pakistan
3
North Macedonia
2
Tajikistan
2
Chile
2
Albania
2
Canada
2
Italy
2
Haiti
2
Cambodia
2
Guinea-Bissau
2
Jordan
2
North America
2
France
2
United Kingdom
2
Bolivia
2
Argentina
2
Angola
2
Iraq
2
Somalia
2
Ecuador
2
Madagascar
2
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
Serbia
1
Turkey
1
Australia
1
Benin
1
Gambia
1
Kazakhstan
1
Iran
1
Singapore
1
Kyrgyzstan
1
Congo-Brazzaville
1
Uzbekistan
1
Afghanistan
1
Burundi
1
Malaysia
1
Morocco
1
Qatar
1
Bulgaria
1
Armenia
1
Dominican Republic
1
Paraguay
1
Luxembourg
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Portugal
1
Lebanon
1
Papua New Guinea
1
Nicaragua
1
Moldova
1
Sri Lanka
1
Djibouti
1
Georgia
1
Honduras
1
Libya
1
Bhutan
1
Botswana
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
499
Clinical Guidelines
206
Key Resources
148
Public Health
106
Women & Child Health
61
Pharmacy & Technologies
51
Capacity Building
34
Annual Report MEDBOX
1
Toolboxes
AMR
262
COVID-19
261
Rapid Response
166
Planetary Health
146
Ebola
120
NTDs
98
TB
93
HIV
92
Pharmacy
47
Caregiver
34
Global Health Education
33
Refugee
30
Zika
29
Mental Health
28
Conflict
23
Natural Hazards
20
Cholera
19
NCDs
19
Specific Hazards
16
Polio
15
Health Financing Toolbox
9
Disability
4
Social Ethics
1
PLOS One November 20, 2020 https://doi.org/10.1371/journal.pone.0241799 . The first autochthonous case of chikungunya virus (CHIKV) infection in Brazil was in September 2014 in the State of Amapá, and from there it rapidly spread across the country. The present study was conducted in 2016 in the st...
It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
This strategy defines the World Health Organization (WHO) vision and framework for supporting Member States to accelerate the development, implementation and monitoring of their National Action Plan for Health Security (NAPHS) from 2022 to 2026. The National Action Plan for Health Security (NAPHS) ...
Revised and expanded version of the Guidelines
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. The disease is endemic in certain areas of the World...
This is an e-learning module with the objective of providing education for health professionals and pregnant women using published results and studies based on COVID-19 surveillance data, which have indicated an increased risk among pregnant women of presenting with severe forms of COVID-19 and, the...
Leptospirosis, a spirochaetal zoonosis, occurs in diverse epidemiological settings and affects vulnerable populations, such as rural subsistence farmers and urban slum dwellers. Although leptospirosis is a life-threatening disease and recognized as an important cause of pulmonary haemorrhage syndrom...
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based, ...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou...
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
